Drug Type Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Action inhibitors |
Mechanism MMP1 inhibitors(Matrix metalloproteinase-1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adenocarcinoma of Lung | Clinical | United Kingdom | 21 Apr 2025 |